Click here to view this email in your web browser
 
 
INFO CLIP | Xtra By Vue Point
January 26, 2017
Canadian Eye Care Business Review
BEST OF VMAIL For Canadian Eye Care Professionals
 
 
 
VuePoint_CECBR_634x90
 
 
 
 
 
Xtra
 
 
 
 
 
Eschenbach Appoints New CFO
 
Eschenbach announces the appointment of Taron Sutcliffe as new Chief Financial Officer, effective December 28, 2016. [+]
 
 
 
 
 
Update: Industry Leaders Respond to Essilor-Luxottica Merger
 
InfoClip will be posting Canadian industry reaction to the ground-shifting mega deal between the two industry behemoths. [+]
 
 
 
 
 
Symposium on Retinopathy of Prematurity Treatment Options
 
The Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) has devoted a mini-symposium to the latest developments and new techniques for treating retinopathy of prematurity (ROP). [+]
 
 
 
 
 
 
 
Canadian Eye Care Business Review
 
 
 
 
 
Canadian Eye Care Business Review – Launch Announcement
Drs. Jeff & Tina Goodhew discuss the launch of Canadian Eye Care Business Review, how it fits into the Canadian Eye Care Space and their vision for the future. [+]
 
 
 
5 Key Patient Touch Points That Built a $1 Million Practice
5 Key patient touch points that are designed to enhance the patient experience and help ensure long term practice growth. [+]
 
 
 
Website Design 2017: 7 Things You Need To Know
7 things you need to know for your eye care practice website in 2017. [+]
 
 
 
Scribes: Give Patients Your Full Attention & Improve Work Flow
Scribes in the exam room allow you to concentrate fully on your patient, improving your office’s work flow and enhancing the care you provide. [+]
 
 
 
 
 
 
 
 
BEST OF VMAIL For Canadian Eye Care Professionals
 
 
 
 
 
Novartis Considering Options for Alcon Division, Including Spinoff or IPO [+]
 
 
 
 
 
Eye Care Leaders Launches Eye Care Visionaries at Hawaiian Eye Meeting [+]
 
 
 
 
 
Mark Humayun, MD, PhD, Named Keynote Speaker for Envision Conference [+]
 
 
 
 
VMail is a news service of Vision Monday
 
 
 
VUEPoint_autopromo_classifieds_634x90_EN
 
 
 
 
Classifieds
 
 
Career Opportunities
 
IMPLEMENTATION SPECIALIST – EYECARE SOFTWARE – OPTOSYS®
Nº 2446 | We are currently seeking an Optical Specialist. Yo...
 
 
TERRITORY MANAGER
 
TERRITORY MANAGER
Nº 2450 | Modo, a respected niche eyewear company based in New York is looking to expand its Sales team. Jo...
 
 
SALES REPRESENTATIVE
Nº 2454 | Company Name: Mood Eyewear/Lunettes Inc Location:...
 
 
TEAM LEADS (CUSTOMER SERVICE AND MANUFACTURING/PRODUCTION)
Nº 2468 | If you would like to be a part of this progressive...
 
 
TECHNICIANS (FINISHING, COATING, AND SURFACING)
Nº 2469 | If you would like to be a part of this progressive...
 
 
 
Services
 
March 20th, 2017 6-month Dispensing and Contact Lens Fitting class
Nº 1607 | BC COLLEGE OF OPTICS... our next fast-paced 6-mont...
 
 
CUSTOM INTERIOR & DISPLAYS
 
CUSTOM INTERIOR & DISPLAYS
Nº 2196 | Our Goal - Your Benefits Enjoy a complimentary consultation on us! We will collaborate with yo...
 
 
OPTICAL DISPLAYS & INTERIOR DESIGN
 
OPTICAL DISPLAYS & INTERIOR DESIGN
Nº 2364 | Whether you are doing a remodel or planning a build-out - we will guide you smoothly through the who...
 
 
 
Top Feedback
 
 
 
Powered by | VuePointIDS
 
Facebook   Twitter   Linkedin   Mail
 
1 844 235 8562 • vuepoint.ca
 
512 Woolwich Street #4
Guelph ON N1H 3X7
(226) 780 6871

10 Churchill Blvd, suite 202
Greenfield Park QC J4V 2L7
(438) 795 7531
 
 
©2015 – All rights reserved, VuePoint IDS Inc.
 
The content of the advertisements and advertorials is that of the advertisers and does not reflect the opinion of the publisher.
 
You’re receiving this email because you are listed in the VuePoint IDS Inc. distribution list.
 
VMail Headlines is a service of Jobson Medical Information LLC, the publisher of VisionMonday®, 100 Avenue of the Americas, New York, New York 10013.
 
Click HERE to confirm your consent to receiving our publications or to modify your preferences or profile.
 
To unsubscribe, click HERE. Please allow 10 days to take effect.
 
 
- - - - - - - - - - - - - - - - - - - - - -